Skip to main content
Premium Trial:

Request an Annual Quote

Dharmacon, Wellcome Trust Sanger Institute

Premium

Dharmacon has recently introduced the miRidian microRNA inhibitors and mimics.

According to the company, the inhibitors and mimics are based on known or predicted miRNA sequences for human, mouse and rat as defined in the Wellcome Trust Sanger Institute's miRBase.

MiRNA inhibitors facilitate loss-of-function studies, while miRNA mimics may be useful for gain-of function studies, Dharmacon said.


NOTE: This is the last issue of RNAi News to be published in 2005. We will resume our normal publishing schedule on Jan. 6, 2006.
The Scan

Rise of BA.5

The New York Times reports that the Omicron subvariant BA.5 has become the dominant version of SARS-CoV-2 in the US.

UK Health Secretary Resigns

Sajid Javid, the UK health secretary, resigned along with Chancellor Rishi Sunak, saying they cannot work with Prime Minister Boris Johnson's government, CNN reports.

Clones From Freeze-Dried Cells

A team in Japan has cloned mice from freeze-dried skin cells, according to the Guardian.

Genome Research Papers on Craniosynostosis, Macaque Retrotransposition, More

In Genome Research this week: structural variants in craniosynostosis, LINE-1 activity in rhesus macaque brain, and more.